EPISODE · Nov 12, 2020 · 29 MIN
GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC
from AUAUniversity · host American Urological Association
At the conclusion of this activity, participants will be able to: 1. Describe new and emerging targeted for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy. 2. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC. 3. Facilitate discussions with patients and caregivers regarding RCC treatment options. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29851
What this episode covers
At the conclusion of this activity, participants will be able to: 1. Describe new and emerging targeted for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy. 2. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC. 3. Facilitate discussions with patients and caregivers regarding RCC treatment options. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29851
NOW PLAYING
GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.